Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Mycosis Fungoides 5Colorectal Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Liver Neoplasms 2Keratosis, Actinic 2Carcinoma, Non-Small-Cell Lung 2Tongue Neoplasms 1Stomach Neoplasms 1Sleep Wake Disorders 1Pleural Diseases 1Peptic Ulcer 1Neoplasms 1Mesothelioma, Malignant 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Lymphoid Interstitial Pneumonia 1Hematologic Neoplasms 1Gallbladder Neoplasms 1Fatigue 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 60Cisplatin 38Oxaliplatin 30Capecitabine 28Fluorouracil 21Leucovorin 19pembrolizumab 11Irinotecan 11durvalumab 9130-nm albumin-bound paclitaxel 9Erlotinib Hydrochloride 8Trastuzumab 7Bevacizumab 7Platinum 6Magnetic Resonance Spectroscopy 6Albumin-Bound Paclitaxel 61,2-diaminocyclohexaneplatinum II citrate 6Taxes 5Specimen Handling 5Sorafenib 5Radiotherapy 5Carboplatin 5Docetaxel 4Biopsy 4trifluridine tipiracil drug combination 3dehydroftorafur 3atezolizumab 3Paclitaxel 3Lapatinib 3Interleukin-12 Subunit p35 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Gallbladder Neoplasms × Phototherapy × Clear all
NCT00253617 2013-04-04

Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery

National Cancer Institute (NCI)

Phase 3 Withdrawn
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡